Courtney DiNardo, Eduardo Rodríguez-Arbolí, Jordi Esteve, Olga Salamero, Andrew Brunner, Maria Calbacho, Daniel Deangelo, Noelia Purroy, Josiana Limones, Carmen Jimenez, Hongxiang Hu, Griff McTume, Maria Dolores Jimenez, Javier Estrada, Yili Qian, Soraya Carrancio, Thomas Prebet, Timothy B. Campbell, Michael Pourdehnad, Geoffrey Uy. "BMS-986397, a first-in-class casein kinase 1α (CK1α) degrader in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS): A phase 1 dose escalation study." Blood, 2025. doi:10.1182/blood-2025-1642